Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Lanzillotta

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|June 18, 2020
Advances in the diagnosis and management of IgG4 related diseaseMarco Lanzillotta, Gaia Mancuso, Emanuel Della-Torre
Current Topics in Microbiology and Immunology|January 17, 2017
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment OutcomesMarco Lanzillotta, Emanuel Della-Torre, John H Stone
Modern Rheumatology|August 19, 2022
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectivesMarco Lanzillotta, John H Stone, Emanuel Della-Torre
Annals of the Rheumatic Diseases|January 16, 2020
Dupilumab as a <i>potential</i> steroid-sparing treatment for IgG4-related diseaseEmanuel Della-Torre, Marco Lanzillotta, Mona-Rita Yacoub
European Journal of Internal Medicine|July 22, 2023
B-cell depletion with obinutuzumab for the treatment of IgG4-related diseaseMarco Lanzillotta, Paola Mapelli, Lorenzo Dagna, et al.
Drug and Therapeutics Bulletin|November 17, 2025
GLP-1 agonists-induced autoimmune pancreatitisJasmin Mahajne, Ernestina Angarola, Emanuel Della Torre, et al.
BMJ Case Reports|September 24, 2025
GLP-1 agonists-induced autoimmune pancreatitisJasmin Mahajne, Ernestina Angarola, Emanuel Della Torre, et al.
United European Gastroenterology Journal|December 21, 2024
Update on Autoimmune Pancreatitis and IgG4-Related DiseaseMarco Lanzillotta, Miroslav Vujasinovic, Johannes-Matthias Löhr, et al.
International Journal of Environmental Research and Public Health|November 10, 2020
IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian PatientsAndrea Rampi, Marco Lanzillotta, Gaia Mancuso, et al.
European Journal of Internal Medicine|November 4, 2025
Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related diseaseClaudia Minici, Jasmin Mahajne, Ugo Orfanelli, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|June 18, 2020
Advances in the diagnosis and management of IgG4 related diseaseMarco Lanzillotta, Gaia Mancuso, Emanuel Della-Torre
Current Topics in Microbiology and Immunology|January 17, 2017
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment OutcomesMarco Lanzillotta, Emanuel Della-Torre, John H Stone
Modern Rheumatology|August 19, 2022
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectivesMarco Lanzillotta, John H Stone, Emanuel Della-Torre
Annals of the Rheumatic Diseases|January 16, 2020
Dupilumab as a <i>potential</i> steroid-sparing treatment for IgG4-related diseaseEmanuel Della-Torre, Marco Lanzillotta, Mona-Rita Yacoub
European Journal of Internal Medicine|July 22, 2023
B-cell depletion with obinutuzumab for the treatment of IgG4-related diseaseMarco Lanzillotta, Paola Mapelli, Lorenzo Dagna, et al.
Drug and Therapeutics Bulletin|November 17, 2025
GLP-1 agonists-induced autoimmune pancreatitisJasmin Mahajne, Ernestina Angarola, Emanuel Della Torre, et al.
BMJ Case Reports|September 24, 2025
GLP-1 agonists-induced autoimmune pancreatitisJasmin Mahajne, Ernestina Angarola, Emanuel Della Torre, et al.
United European Gastroenterology Journal|December 21, 2024
Update on Autoimmune Pancreatitis and IgG4-Related DiseaseMarco Lanzillotta, Miroslav Vujasinovic, Johannes-Matthias Löhr, et al.
International Journal of Environmental Research and Public Health|November 10, 2020
IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian PatientsAndrea Rampi, Marco Lanzillotta, Gaia Mancuso, et al.
European Journal of Internal Medicine|November 4, 2025
Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related diseaseClaudia Minici, Jasmin Mahajne, Ugo Orfanelli, et al.
Pageof 7